Evidence map›Paper›PMID 32357288›Full record

ArticleAndrology2021

SARS-CoV-2 pandemic and repercussions for male infertility patients: A proposal for the individualized provision of andrological services.

Sandro C Esteves, Francesco Lombardo, Nicolás Garrido, Juan Alvarez, Armand Zini, Giovanni M Colpi, Jackson Kirkman-Brown, Sheena E M Lewis, Lars Björndahl, Ahmad Majzoub and 17 more

Open access · bronzeAbstract read
In one paragraph

Article in Andrology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Testosterone in COVID-19: An Adversary Bane or Comrade Boon.Frontiers in cellular and infection microbiology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 20 institutions in 18 countries.

Sandro C EstevesANDROFERT, Andrology and Human Reproduction Clinic, Campinas, Brazil.ORCID 0000-0002-1313-9680
Francesco LombardoDepartment of Medical Physiopathology, University of Rome "La Sapienza", Rome, Italy.ORCID 0000-0002-6943-2966
Nicolás GarridoIVI Foundation, Health Research Institute La Fe, Valencia, Spain.ORCID 0000-0001-8271-5218
Juan AlvarezCentro ANDROGEN, La Coruña, Spain.
Armand ZiniDivision of Urology, Department of Surgery, St. Mary's Hospital, McGill University, Montreal, QC, Canada.ORCID 0000-0002-2194-5578
Giovanni M ColpiAndrology Service, Procrea Swiss Fertility Center, Lugano, Switzerland.ORCID 0000-0003-1431-1777
Jackson Kirkman-BrownCentre for Human Reproductive Science, IMSR, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.ORCID 0000-0003-2833-8970
Sheena E M LewisQueens University Belfast, Belfast, UK.ORCID 0000-0001-5665-1572
Lars BjörndahlANOVA, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-4709-5807
Ahmad MajzoubDepartment of Urology, Hamad Medical Corporation, Doha, Qatar.ORCID 0000-0001-7423-6241
Chak-Lam ChoDepartment of Surgery, Union Hospital, Hong Kong, Hong Kong.ORCID 0000-0003-2520-6833
Pedro VendeiraUrology/Andrology Unit, Saúde Atlântica, Clínica do Dragão, Porto, Portugal.
Jorge HallakAndroscience, Science and Innovation Center in Andrology and High-Complex Clinical and Andrology Laboratory, São Paulo, Brazil.ORCID 0000-0002-6452-0502
Edouard AmarCabinet D'Andrologie Victor Hugo, American Hospital of Paris Reproductive Center, Paris, France.
Marcello CocuzzaHuman Reproduction Center, Division of Urology, University of São Paulo, São Paulo, Brazil.ORCID 0000-0002-5465-4304
Fabiola C BentoANDROFERT, Andrology and Human Reproduction Clinic, Campinas, Brazil.ORCID 0000-0003-3772-1357
Rita C FigueiraANDROFERT, Andrology and Human Reproduction Clinic, Campinas, Brazil.
Romualdo SciorioEdinburgh Assisted Conception Programme, EFREC, Royal Infirmary of Edinburgh, Edinburgh, UK.ORCID 0000-0002-7698-8823
Rita J LaursenFertility Clinic Skive, Skive Regional Hospital, Skive, Denmark.
Ahmad M MetwalleyIVF Laboratory, Al Saad Specialist Hospitals, Jeddah, Saudi Arabia.ORCID 0000-0001-5751-9506
Sunil K JindalDivision of Reproductive Medicine and Andrology, Jindal Hospital, Meerut, India.ORCID 0000-0002-8088-8710
Sijo ParekattilPUR Clinic and University of Central Florida, Clermont, FL, USA.ORCID 0000-0001-6847-8826
Ranjith RamasamyDepartment of Urology, Miller School of Medicine, University of Miami, Miami, FL, USA.ORCID 0000-0003-1387-7904
Carlo AlviggiDepartment of Neuroscience, Reproductive Science and Odontostomatology, University of Naples Federico II, Naples, Italy.ORCID 0000-0001-9116-020X
Peter HumaidanFaculty of Health, Aarhus University, Aarhus, Denmark.ORCID 0000-0001-6884-5366
John L YovichPIVET Medical Centre, Perth, WA, Australia.ORCID 0000-0002-9583-3683
Ashok AgarwalAndrology Center, Department of Urology, Cleveland Clinic, Cleveland, OH, USA.ORCID 0000-0003-0585-1026
Center for Human Reproduction · USUniversidade de São Paulo · BRAarhus University · DKAtlântica Instituto Universitário · PTBirmingham Women’s and Children’s NHS Foundation Trust · GBCleveland Clinic · USCurtin University · AUEdinburgh Royal Infirmary · GBFederico II University Hospital · ITHôpital américain de paris · FRInstitute of Reproductive Medicine · INKarolinska University Hospital · SEMcGill University Health Centre · CAQueen's University Belfast · GBSaad Specialist Hospital · SASapienza University of Rome · ITSkive Hospital · DKSwiss Institute for Regenerative Medicine · CHUnion Hospital · CNUniversidade Estadual de Campinas (UNICAMP) · BR

Funding

Department of Health HCS SCL-2014-05-001
6 · The paper itself

Abstract

The prolonged lockdown of health facilities providing non-urgent gamete cryopreservation-as currently recommended by many reproductive medicine entities and regulatory authorities due to the SARS-CoV-2 pandemic will be detrimental for subgroups of male infertility patients. We believe the existing recommendations should be promptly modified and propose that the same permissive approach for sperm banking granted for men with cancer is expanded to other groups of vulnerable patients. These groups include infertility patients (eg, azoospermic and cryptozoospermic) undergoing medical or surgical treatment to improve sperm quantity and quality, as well as males of reproductive age affected by inflammatory and systemic auto-immune diseases who are about to start treatment with gonadotoxic drugs or who are under remission. In both scenarios, the "fertility window" may be transitory; postponing diagnostic semen analysis and sperm banking in these men could compromise the prospects of biological parenthood. Moreover, we provide recommendations on how to continue the provision of andrological services in a considered manner and a safe environment. Our opinion is timely and relevant given the fact that fertility services are currently rated as of low priority in most countries.

Indexed as

COVID-19AndrologyHealth Services AccessibilityHealth Services Needs and DemandHumansInfertility, MaleMaleNeeds Assessmentazoospermiamale infertilityopinionSARS-CoV-2semen analysissperm bankingsystemic auto-immune diseases

Identifiers

PMID32357288
PMCPMC7267121
OpenAlexW3023200394

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.